Re:Pharma companies continue to raise drug prices at rates w...
by entee on Monday October 14, 2019 @01:41PM
(#21250799)
This dynamic already exists in diagnostics. There's a huge second mover advantage in diagnostics because it's relatively hard to patent a diagnostic effectively. I know a few people in diagnostic companies that have very much soured on the industry as a result.
[ Parent
| on HN ]
There are no comments on this comment yet.